Global Cord Blood's revenue for the
three
months ended in Mar. 2022 was $46.8 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2022 was $194.3 Mil.
Global Cord Blood's Revenue per Share for the
three
months ended in Mar. 2022 was $0.39.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 was $1.60.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
Global Cord Blood Revenue Historical Data
The historical data trend for Global Cord Blood's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Global Cord Blood's Revenue
For the Diagnostics & Research subindustry, Global Cord Blood's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Cord Blood's Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Revenue distribution charts can be found below:
* The bar in red indicates where Global Cord Blood's Revenue falls into.
Global Cord Blood Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $194.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Cord Blood (OTCPK:CORBF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Global Cord Blood Revenue Related Terms
Thank you for viewing the detailed overview of Global Cord Blood's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Global Cord Blood (Global Cord Blood) Business Description
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CORBF has been successfully added to your 